Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Ellenville › NPI 1073525341
Hospital

Westchester-Ellenville Hospital, INC.

Westchester-Ellenville Hospital, INC. was paid $11.13M by Medicaid between Jul 2018 and Dec 2024, across 76 billing codes. Its largest line is 99283, emergency room visit (moderate) — 44% of everything it billed.

33Billing provider infoWESTCHESTER-ELLENVILLE HOSPITAL, INC.
ELLENVILLE, NY 12428
33aNPI1073525341assigned 08/13/2006
28Total paid$11.13M
24GClaims86,601
24DCodes billed76
24AFirst – last monthJul 2018 – Dec 2024
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201821$1K
20196,709$383K
202012,211$832K
202117,632$1.25M
202219,238$3.89M
202320,108$3.44M
2024incomplete10,682$1.33M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 44% 14,237 13,350 $4.85M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 17% 6,676 6,236 $1.89M
99282 Emergency department visit for the evaluation and management, low to moderate severity 16% 4,552 4,425 $1.73M
80053 Comprehensive metabolic panel 5.9% 6,272 5,576 $656K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.7% 8,393 2,399 $407K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.6% 1,260 1,199 $291K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.9% 2,164 2,032 $215K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.6% 946 924 $173K
70450 Computed tomography, head or brain; without contrast material 1.5% 684 672 $165K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 504 494 $88K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 433 316 $85K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 1,164 410 $83K
64 more codes
97164 <1% 615 $72K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,925 $55K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 217 $54K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,046 $39K
97162 <1% 231 $38K
97010 <1% 3,225 $36K
12011 <1% 104 $29K
20610 <1% 84 $27K
80048 Basic metabolic panel (calcium, ionized) <1% 235 $26K
77067 Screening mammography, bilateral, including computer-aided detection <1% 377 $21K
36415 Collection of venous blood by venipuncture <1% 1,462 $13K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 67 $10K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,054 $10K
97161 <1% 111 $10K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 3,462 $8K
90715 <1% 80 $7K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 156 $7K
83880 <1% 79 $4K
71046 Radiologic examination, chest; 2 views <1% 736 $4K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 15 $3K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 787 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 12 $3K
96375 Therapeutic injection; each additional sequential IV push <1% 2,324 $2K
77063 Screening digital breast tomosynthesis, bilateral <1% 345 $2K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 1,573 $2K
71045 Radiologic examination, chest; single view <1% 1,161 $1K
73610 <1% 176 $1K
73630 <1% 203 $1K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 3,285 $1K
81001 <1% 1,350 $868.75
97014 <1% 35 $581.40
73562 <1% 127 $564.01
97116 <1% 38 $544.75
76830 Ultrasound, transvaginal <1% 15 $537.30
87430 <1% 733 $505.74
84484 <1% 1,006 $465.22
87400 <1% 617 $418.02
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 25 $380.76
73130 <1% 73 $330.28
93041 <1% 936 $305.49
86769 <1% 17 $294.91
83690 <1% 963 $261.14
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 78 $138.87
73030 <1% 31 $108.55
72100 <1% 13 $104.69
84703 <1% 1,345 $84.34
83735 <1% 406 $65.51
J7030 Infusion, normal saline solution , 1000 cc <1% 1,855 $61.26
73110 <1% 15 $57.51
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 914 $39.19
87070 <1% 191 $36.47
83605 <1% 13 $25.65
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 178 $24.07
81003 <1% 332 $24.00
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 715 $20.08
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 577 $19.51
87807 <1% 32 $10.48
87086 Culture, bacterial; quantitative colony count, urine <1% 58 $8.07
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 29 $2.37
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 308 $2.18
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 0% 37 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 0% 29 $0.00
85730 0% 24 $0.00
85610 0% 54 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKELLEY, STEVEN (PRESIDENT & CEO)